154 related articles for article (PubMed ID: 38606094)
1. Second malignant neoplasms within 5 years from first primary diagnosis in pediatric oncology patients in Canada: a population-based retrospective cohort study.
Ricci C; Subburaj D; Lim K; Shukla N; Kaur J; Xie L; Laverty M; Zakaria D; Pole J; Pelland-Marcotte MC; Barber R; Israels SJ; Tran TH; Oberoi S; Renzi S; MacDonald T; Sung L; Kulkarni K
Front Oncol; 2024; 14():1376652. PubMed ID: 38606094
[TBL] [Abstract][Full Text] [Related]
2. Second malignant neoplasms among children, adolescents and young adults with Wilms tumor.
Lee JS; Padilla B; DuBois SG; Oates A; Boscardin J; Goldsby RE
Pediatr Blood Cancer; 2015 Jul; 62(7):1259-64. PubMed ID: 25809878
[TBL] [Abstract][Full Text] [Related]
3. Incidence, Risk Factors, and Mortality Associated With Second Malignant Neoplasms Among Survivors of Adolescent and Young Adult Cancer.
Chao C; Bhatia S; Xu L; Cannavale KL; Wong FL; Huang PS; Cooper R; Armenian SH
JAMA Netw Open; 2019 Jun; 2(6):e195536. PubMed ID: 31173129
[TBL] [Abstract][Full Text] [Related]
4. Subsequent malignant neoplasms in pediatric cancer patients treated with and without hematopoietic SCT.
Pole JD; Darmawikarta D; Gassas A; Ali M; Egler M; Greenberg ML; Doyle J; Nathan PC; Schechter T
Bone Marrow Transplant; 2015 May; 50(5):721-6. PubMed ID: 25706885
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of second malignant neoplasms in adolescents and young adults with cancer.
Lee JS; DuBois SG; Coccia PF; Bleyer A; Olin RL; Goldsby RE
Cancer; 2016 Jan; 122(1):116-23. PubMed ID: 26441212
[TBL] [Abstract][Full Text] [Related]
6. Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.
Franklin J; Eichenauer DA; Becker I; Monsef I; Engert A
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD008814. PubMed ID: 28901021
[TBL] [Abstract][Full Text] [Related]
7. Utility of a Cancer Predisposition Screening Tool for Predicting Subsequent Malignant Neoplasms in Childhood Cancer Survivors.
Cullinan N; Schiller I; Di Giuseppe G; Mamun M; Reichman L; Cacciotti C; Wheaton L; Caswell K; Di Monte B; Gibson P; Johnston DL; Fleming A; Pole JD; Malkin D; Foulkes WD; Dendukuri N; Goudie C; Nathan PC
J Clin Oncol; 2021 Oct; 39(29):3207-3216. PubMed ID: 34383599
[TBL] [Abstract][Full Text] [Related]
8. Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976: follow-up of a Children's Oncology Group cohort.
Goldsby R; Burke C; Nagarajan R; Zhou T; Chen Z; Marina N; Friedman D; Neglia J; Chuba P; Bhatia S
Cancer; 2008 Nov; 113(9):2597-604. PubMed ID: 18823030
[TBL] [Abstract][Full Text] [Related]
9. Second malignant neoplasms after childhood cancer: A nationwide population-based study in Korea.
Ju HY; Moon EK; Lim J; Park BK; Shin HY; Won YJ; Park HJ
PLoS One; 2018; 13(11):e0207243. PubMed ID: 30440007
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort.
Turcotte LM; Liu Q; Yasui Y; Henderson TO; Gibson TM; Leisenring W; Arnold MA; Howell RM; Green DM; Armstrong GT; Robison LL; Neglia JP
J Clin Oncol; 2019 Dec; 37(34):3310-3319. PubMed ID: 31622130
[TBL] [Abstract][Full Text] [Related]
11. Corrigendum: Second malignant neoplasms within 5 years from first primary diagnosis in pediatric oncology patients in Canada: a population-based retrospective cohort study.
Ricci C; Subburaj D; Lim K; Shukla N; Kaur J; Xie L; Laverty M; Zakaria D; Pole J; Pelland-Marcotte MC; Barber R; Israels SJ; Tran TH; Oberoi S; Renzi S; MacDonald T; Sung L; Kulkarni K
Front Oncol; 2024; 14():1418512. PubMed ID: 38800386
[TBL] [Abstract][Full Text] [Related]
12. Second malignancies in patients with neuroblastoma: the effects of risk-based therapy.
Applebaum MA; Henderson TO; Lee SM; Pinto N; Volchenboum SL; Cohn SL
Pediatr Blood Cancer; 2015 Jan; 62(1):128-33. PubMed ID: 25251613
[TBL] [Abstract][Full Text] [Related]
13. Cancer incidence, morbidity, and survival in Canadian first nation children: a Manitoba population-based study from the cancer in young people in Canada (CYP-C) registry.
Stammers DM; Israels SJ; Lambert PJ; Cuvelier GD
Pediatr Blood Cancer; 2014 Dec; 61(12):2164-9. PubMed ID: 24616082
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and survival patterns of subsequent sarcoma, breast cancer, and melanoma after childhood cancer in the DCOG-LATER cohort.
Teepen JC; Kremer LC; van der Heiden-van der Loo M; Tissing WJ; van der Pal HJ; van den Heuvel-Eibrink MM; Loonen JJ; Louwerens M; Versluys B; van Dulmen-den Broeder E; Visser O; Maduro JH; van Leeuwen FE; Ronckers CM;
Cancer Causes Control; 2019 Sep; 30(9):909-922. PubMed ID: 31300947
[TBL] [Abstract][Full Text] [Related]
15. Tandem High-Dose Chemotherapy Increases the Risk of Secondary Malignant Neoplasm in Pediatric Solid Tumors.
Lim H; Im M; Seo ES; Cho HW; Ju HY; Yoo KH; Cho SY; Kim JW; Lim DH; Sung KW; Lee JW
Cancer Res Treat; 2024 Apr; 56(2):642-651. PubMed ID: 37997325
[TBL] [Abstract][Full Text] [Related]
16. Increased Cardiac Risk After a Second Malignant Neoplasm Among Childhood Cancer Survivors: A FCCSS Study.
Charrier T; Haddy N; Schwartz B; Journy N; Fresneau B; Demoor-Goldschmidt C; Diallo I; Surun A; Aerts I; Doz F; Souchard V; Vu-Bezin G; Laprie A; Lemler S; Letort V; Rubino C; Chounta S; de Vathaire F; Latouche A; Allodji RS
JACC CardioOncol; 2023 Dec; 5(6):792-803. PubMed ID: 38205003
[TBL] [Abstract][Full Text] [Related]
17. Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma.
Lee JS; DuBois SG; Boscardin WJ; Wustrack RL; Goldsby RE
Cancer; 2014 Dec; 120(24):3987-93. PubMed ID: 25116228
[TBL] [Abstract][Full Text] [Related]
18. Secondary neoplasms after radiotherapy for a childhood solid tumor.
Paulino AC; Fowler BZ
Pediatr Hematol Oncol; 2005 Mar; 22(2):89-101. PubMed ID: 15804994
[TBL] [Abstract][Full Text] [Related]
19. Increased Risk of Suicide among Cancer Survivors Who Developed a Second Malignant Neoplasm.
Yang H; Qu Y; Shang Y; Wang C; Wang J; Lu D; Song H
Comput Intell Neurosci; 2022; 2022():2066133. PubMed ID: 35047029
[TBL] [Abstract][Full Text] [Related]
20. Subsequent Malignant Neoplasms in a Population-Based Cohort of Pediatric Cancer Patients: A Focus on the First 5 Years.
Pole JD; Gu LY; Kirsh V; Greenberg ML; Nathan PC
Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1585-92. PubMed ID: 26189768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
